Prodia Diagnostic Line Tbk vs Tigaraksa Satria Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 10.51M 24h volume), while Tigaraksa Satria Tbk. trades at Rp5,175 (market cap 4.57T, 1K 24h volume). The key difference: Tigaraksa Satria Tbk. is far larger — about 9.7× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (10.51M versus 1K). Which is the better fit depends on your goals.
| PRDL | TGKA | |
|---|---|---|
Market Cap | 470.58B | 4.57T |
Volume | 10.51M | 1K |
Lot | 105.13K | 10 |
Turnover | 2.77B | 5.2M |
Average Price | 263.08 | 5,197.5 |
Value | 2.77B | 5.2M |
Indicative Equilibrium Price | 272 | — |
Indicative Equilibrium Volume | 418 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Tigaraksa Satria Tbk (the Company) was established in Jakarta based on notarial deed No. 35 of M.M.I. Wiardi, S.H., dated November 17, 1986. PT. Tigaraksa Satria is a distributor of Nutrition, Chemicals, Cosmetic, Books, Garments and other consumer goods. Founded in 1987 as a subsidiary of PT. Tigaraksa, the company handles the dosmetic distribution products for more than 20 pricipals.
Read more on TGKA →